Chapter 62: The Physiology of Aging

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

Welcome deep divers.

Imagine this.

Back in 1900, the average life expectancy for a man in the United States was under 48 years.

Wow.

Yeah.

And for women, barely 50.

But then fast forward to 2002, those numbers had leaped.

We're talking 74 and a half for men and nearly 80 for women.

That's a revolutionary change.

Huge.

It really is.

But what's surprising is that this massive increase in human lifespan during the 20th century was, well, initially kind of overlooked by a lot of biomedical science.

It actually wasn't until 1974 that the U .S.

established the National Institute on Aging, the NIA.

That was a real turning point.

It really clicked off serious global research into, you know, what it means to grow old.

Today, we're embarking on a deep dive into the physiology of aging.

We're drawing directly from medical physiology by Boron and Bull Pape, a cornerstone text really for anyone in medicine or the life sciences.

Absolutely essential reading.

Our mission is to sort of unravel these complex mechanisms of aging, make them clear, conversational and, yeah, clinically relevant for you.

Think of this as your essential last minute lecture to connect the dots, to really empower your understanding.

Exactly.

Our goal is to take these, well, these big, intricate physiological ideas and break them down into understandable steps.

We want to show you how these seemingly isolated details, whether they're cellular processes or changes in organ systems, how they all connect to the bigger picture, you know, diagnostics, pathology, and ultimately treatment.

Understanding these fundamental mechanisms, it's not just about memorizing facts.

You're gaining real insight into how the human body works as we age.

OK, let's start unpacking this by setting the scene.

The landscape of aging itself, it's constantly shifting.

And one of the most striking changes, especially in developed nations, is how our populations have dramatically shifted towards older individuals.

Yeah, the demographics are undeniable.

Take the U .S.

example.

In 1900, only about 4 % of the population was 65 or older, just 4%.

Tiny fraction.

By 1990, that number shot up to 13%, and it's still climbing.

And here's a fascinating detail.

Women make up a much larger chunk of the very old.

That's right.

Significantly larger.

In 1990, something like 70 .5 % of people over 80 in developed nations were women.

What's behind that difference?

What's really interesting is that this initial shift, the one during the 20th century, it was less about a huge jump in life expectancy from birth and more about falling birth rates, steadily falling birth rates.

If fewer babies are born, the elderly naturally become a larger slice of the pie, you see.

Oh, that makes sense.

You can see it really clearly with the post -World War II baby boom.

That generation created this massive bulge in the population structure that's, well, profoundly impacted demographics as they've aged.

Right, the boomers.

Exactly.

But looking ahead, since birth rates probably won't fall much further, future shifts in population age will depend much more on further increases in life expectancy from birth.

Okay, so that's the population level.

But what about measuring aging in an individual?

You mentioned that's still a quest.

And when we even talk about aging, what exactly do we mean?

It seems simple, but maybe it's not.

Yeah, it's trickier than it sounds.

Colloquially, sure, aging means your chronological age.

How many candles on the cake?

Yeah, right.

But bio -gerontologists, scientists studying aging, often use aging synonymously with senescence.

Senescence.

Okay, what's the formal definition there?

Senescence is defined as the progressive, deteriorative changes during the adult period of life which underlie an increasing vulnerability to challenges, and thereby decrease the ability of the organism to survive.

So it's about decline in vulnerability.

Precisely.

So when someone says, oh, she's young for her age, they're basically saying she shows slower senescence.

This gets at the idea of biological age versus chronological age.

Biological age.

We recognize it exists, this biological age, but we don't have a universally agreed -upon way to measure it quantitatively.

The search for reliable biomarkers of aging things we can actually measure is still ongoing.

Okay, no single test yet.

But for populations, how do they measure aging then?

You mentioned

Gompertz.

Basically,

the fraction of a population entering a certain age group, say 70 -75, that then dies during that interval.

And he found that after early adulthood, this death rate increases exponentially with age.

If you plotted it, the curve just shoots upwards.

It reflects population aging generally, though even that's been challenged a bit more recently.

Interesting.

So let's shift gears a bit.

How did aging even evolve?

Why do we do it?

That's a big one.

And the thinking has changed dramatically.

The old idea was that maybe aging was some kind of evolutionary adaptation, like it was programmed.

It's programmed for the good of the species or something.

Yeah.

But the current view is very different.

We now think aging evolved mostly by default.

By default?

How so?

It reflects the absence of strong natural selection against mutations that only cause problems late in life.

Think about it.

In a harsh natural environment, historically, very few individuals live long enough for those late -acting, harmful genes to even show their effects.

So natural selection couldn't weed them out because most individuals were already gone by then.

Exactly.

Selection just didn't see them effectively.

This led to, well, three key evolutionary theories or mechanisms that likely work together.

Okay.

What are they?

First, there's Medawar's mutation accumulation idea from 1952.

He suggested that harmful mutations get weeded out if they affect young individuals, but mutations that only cause trouble at advanced ages.

They just accumulate in the gene pool because selection is weak back there.

Makes sense.

What's number two?

Second, and this one is really fascinating, is Williams' antagonistic pleiotropy from 1957.

Antagonistic pleiotropy.

Sounds complex.

The idea is that a single gene can have multiple effects.

That's pleiotropy.

And sometimes a gene might have beneficial effects early in life, like boosting reproduction or development.

Okay.

Good for fitness early on.

Right.

Strongly favored by natural selection then.

But that same gene might have harmful deleterious effects much later in life.

Ah, the antagonistic part.

Good early, bad late.

Exactly.

So aging, in this view, is kind of an unavoidable byproduct, a tradeoff for those early life advantages that boost evolutionary fitness.

Wow.

Okay, that's a powerful idea.

And the third one.

Third is Kirkwood's disposable soma theory from 1977.

Soma just means the body, as opposed to the germline cells.

Got it.

This theory suggests there's a fundamental tradeoff in how organisms allocate energy.

You can invest energy in reproduction,

or you can invest it in maintaining and repairing the body, the soma, indefinitely.

Okay, energy budget.

Right.

Evolutionarily, especially in harsh environments where lifespan is likely short anyway, it makes more sense to prioritize energy for reproduction, passing on your genes, rather than investing heavily in perfect long -term body maintenance.

So the body is sort of disposable after reproduction?

In a way, yes.

Less energy goes to repair, damage accumulates, and that contributes to aging.

It's about resource allocation priorities shaped by the environment.

And these three theories aren't mutually exclusive, they likely all play a role.

That's a really helpful framework for thinking about why we age.

But okay, let's get practical.

How do scientists actually study aging in humans?

You mentioned our long lifespans are a hurdle.

Oh, it's a huge hurdle.

The investigator's scientific lifespan is shorter than the subject's lifespan.

Right.

So researchers mainly rely on two broad study designs.

The first is the cross -sectional design.

Cross -sectional?

What's that involve?

You study different groups of people representing different age ranges, all at one brief point in time.

So you might compare cognitive function in groups of 20 -year -olds, 40 -year -olds, 60 -year -olds, and 80 -year -olds, all tested within, say, the same year.

Seems efficient.

What are the downsides?

Two big ones.

Major pitfalls.

First is the cohort effect.

Cohort effect.

Yeah, different age groups grew up in different eras.

They had different environments, nutrition, education levels, exposures.

So if you find cognitive differences,

is it aging?

Or is it because the 80 -year -old cohort have less formal education on average than the 20 -year -old cohort?

Oh, okay.

Different life experiences confounding things.

Exactly.

The second pitfall is selective mortality.

Selective mortality.

Meaning that individuals with risk factors for early death are, well, less likely to survive into the older age groups.

Imagine studying cholesterol levels.

People with very high LDL cholesterol might die young from heart disease.

So they're missing from your older sample.

Precisely.

They've been selectively removed, which can make the older group look healthier or have lower average cholesterol than they otherwise would.

It biases the results.

Okay, so cross -sectional studies have these built -in potential biases.

What's the alternative?

The alternative is the longitudinal design.

Here, you study the same group of individuals repeatedly over a significant portion of their lifetime.

You might enroll people in their 40s and test them every five years until they're in their 80s.

That sounds much better.

Avoids cohort effects and selective mortality issues, right?

It does avoid those specific problems, yes.

But it comes with its own set of serious challenges.

Ah, okay.

Like what?

Well, first,

they're incredibly expensive and require stable, long -term organizational structures.

Decades of funding and consistent staffing.

I can imagine.

Then there's the effect of repeated measurements.

Just being tested repeatedly might change people's behavior or performance.

People might change their lifestyle over time.

Subjects drop out, they move, they lose interest, they pass away.

Right.

And think about technology.

Measurement techniques and equipment might change over the decades the runs, making comparisons tricky.

Yeah, lots of practical hurdles.

So neither design is perfect.

Nope.

Researchers often try to combine approaches or use sophisticated statistical methods to account for these limitations.

But studying human aging remains fundamentally challenging.

This actually leads nicely into another big question, maybe even a controversy.

Age -associated diseases.

Things like heart disease, stroke, many cancers, type 2 diabetes, Alzheimer's, Parkinson's, they overwhelmingly affect older people.

Are these diseases actually part of aging itself or something separate?

That is a really key debate in the field and there isn't universal agreement.

Okay.

So what are the main viewpoints?

The majority view held by most gerontologists is that these common age -associated diseases are not an integral part of the fundamental aging process.

They see them as separate.

Yes.

They distinguish between primary aging, which they see as the intrinsic inevitable deteriorative changes happening even in the absence of disease and secondary aging.

Secondary aging.

Secondary aging refers to changes that result from primary aging interacting with environmental factors, lifestyle choices, or specific diseases.

So heart disease would fall under secondary aging in this view.

Okay.

That's the majority view.

What's the other side?

There's a minority view that argues this distinction between primary and secondary aging isn't really fundamental.

They propose that the underlying genetic and molecular mechanisms that drive primary aging might also be responsible for increasing susceptibility to these age -associated diseases.

So maybe the line isn't so clear cut.

Exactly.

They might argue that the processes are deeply intertwined.

It definitely raises an important question for all of us, especially you listeners, to think about.

Is that distinction truly meaningful or are these diseases just the perhaps inevitable manifestations of the aging process in our modern environment?

That's a lot to chew on.

Okay.

Let's pivot now.

Let's zoom right in.

From the big picture down to the micro world,

the cellular and molecular mechanisms of aging,

where does it all start?

Right down at the nuts and bolts.

Fundamentally, the basic mechanism of aging seems to be a long term imbalance.

An imbalance between the constant molecular damage our cells endure and the repair process is designed to fix it.

Damage versus repair.

Exactly.

For a while in adulthood,

damage and repair are roughly in balance, in equilibrium.

But over time, that balance tips.

Damage starts to outpace repair.

And that leads to deterioration.

Yes.

And the specific factors causing this imbalance, the specific types of damage that accumulate, can vary a lot between individuals.

Genetics plays a role.

Environment plays a role.

Okay.

So damage accumulation.

One of the big theories here involves oxidative stress, right?

I remember hearing about the old rate of living theory.

Yeah.

The idea from Rubner and Pearl,

linking metabolic rate to lifespan, faster metabolism, shorter life.

Right.

Like burning a candle faster.

Right.

But you said that was debunked.

Pretty much.

Yeah.

Later evidence didn't really support that simple relationship across different species or within species.

But the focus shifted to the byproducts of metabolism,

specifically reactive oxygen species, or ROS.

Okay.

What are those exactly?

These are highly reactive molecules, often containing oxygen.

Think hydrogen peroxide, the hydroxyl radical, which is really nasty, the superoxide andean radical.

Many are free radicals.

Free radicals.

I've heard that term.

What makes them radical?

They have an unpaired electron in their outer orbital.

Electrons like to be paired up.

So this makes the molecule extremely unstable and chemically reactive.

It desperately wants to steal an electron from another nearby molecule.

Setting off a chain reaction.

Exactly.

It damages the molecule it steals from, often turning that molecule into a radical, which then attacks another, and so on.

This chain reaction can damage crucial things like proteins, lipids and cell membranes, and even DNA.

Sounds bad.

Are ROS always harmful?

Not always.

That's important.

ROS actually play vital physiological roles, too.

We use them to make thyroid hormone, our immune cells use them to kill bacteria.

Even nitric oxide, a key signaling molecule, is technically a free radical.

Okay, so it's about balance again.

Where does most of this damaging ROS come from?

The most significant source inside our cells is actually the process of generating energy in the mitochondrial electron transport chain.

Our cellular power plants.

Right.

As electrons are passed along this chain to eventually make ATP,

a small percentage, maybe one, two percent, leak and accidentally react with oxygen to form the superoxide radical.

This can then be converted to hydrogen peroxide, and under certain conditions, that can generate the highly reactive hydroxyl radical.

So the very process of making energy creates these damaging byproducts.

Correct.

It's an inherent inefficiency.

Fortunately, our bodies aren't defenseless.

We have powerful antioxidant defenses.

Like vitamins.

Yes.

Low molecular weight antioxidants like vitamin C and vitamin E play a role, but we also have potent enzymatic defenses.

Enzymes like superoxide dismutases, SODs, catalase, gluosinoid peroxidase, they specifically target and neutralize different ROS.

So we have ROS production and antioxidant defenses.

And the oxidative stress theory of aging basically proposes that aging is, in large part, caused by a low level imbalance over time between this ROS production and our ability to neutralize them with antioxidants.

Damage accumulates faster than it can be repaired.

Got it.

Oxidative stress is one big player.

What else is going on at the molecular level?

You mentioned glycation.

Yes.

Glycation and glycoxidation.

This is sort of the sugary side of aging damage.

Sugary.

How so?

Glycation refers to non -enzymatic reactions, meaning they happen spontaneously, without needing enzymes between reducing sugars like glucose and macromolecules, especially proteins, but also DNA.

Glucose just randomly sticking to proteins.

Essentially, yes.

An open chain form of glucose can react with an amino group on a protein, forming an initial product.

Over time, through rearrangements and further reactions, often involving oxidation, that's the glycoxidation part, these form stable complex structures called advanced glycation end products, or AGs.

AGs.

Advanced glycation end products.

Right.

Think about browning food when you cook it, that's partly due to similar reactions between sugars and proteins, forming melanoidins.

AGs are kind of like that, but happening slowly inside your body over years.

And why are AGEs a problem?

They become particularly important for long -lived proteins.

Proteins that aren't turned over or replaced very often, like collagen in connective tissue, or crystallins in the lens of the eye.

Okay, so they build up on these stable structures.

Exactly.

Anthony Cerami proposed the glycation hypothesis of aging, noting that the aging phenotype, the outward signs of aging, shares similarities with the complications seen in diabetic patients who have chronically high blood sugar, hyperglycemia, leading to accelerated glycation.

What kind of damage do AGEs cause?

They can alter the structure and function of proteins.

They can cross -link proteins together, making tissues stiffer.

Think about blood vessels losing elasticity.

They can contribute to lens opacification, causing cataracts, and they might also damage DNA.

Okay, so we have oxidative damage and glycation damage.

What about the core components, mitochondria and DNA?

Absolutely central.

Mitochondria, as we said, are major sources of ROS, but they're also major targets of that same oxidative damage.

A double whammy.

Yeah, and their own DNA, the mitochondrial DNA or MTDNA, is particularly vulnerable.

Unlike the DNA in your cell nucleus, which is wrapped around protective histone proteins,

MTDNA is relatively naked.

More exposed to damage.

Much more exposed.

This leads directly to the mitochondrial theory of aging.

The idea is that accumulating damage to MTDNA impairs the mitochondria's ability to produce ATP efficiently.

Less energy production leads to loss of cell function and ultimately contributes to organismal aging.

Makes sense.

Energy failure at the cellular level.

What about the main DNA, the genomic DNA in the nucleus?

That gets damaged too.

From radiation, environmental toxins, but also significantly from oxidative stress generated both inside and outside the mitochondria.

Our cells have extensive DNA repair mechanisms, sophisticated machinery to fix breaks, mismatches, and chemically altered bases.

But the repair isn't perfect.

It's very good, but not perfect, and maybe it declines with age.

The DNA damage theory of aging proposes that over time, unrepaired DNA damage accumulates.

This accumulated damage can interfere with crucial processes like DNA replication when cells divide, and transcription when genes are read to make proteins.

So faulty blueprints or instructions.

Right.

Impaired cell function follows.

Now, whether DNA damage alone is sufficient to cause the overall deterioration of aging is still debated, but it's certainly considered a major contributor.

So it seems like a lot of these theories focus on the damage itself.

Oxidative, glycation, DNA damage.

They do.

But there's another important perspective, maybe even a shift in focus for many biogerontologists now.

They argue that maybe aging isn't so much about the rate of damage generation, which might be relatively constant, but more about a progressive age -associated decline and the ability to repair that damage.

So the repair side of the equation weakens.

Exactly.

This leads to the DNA repair theory of aging, for example.

If DNA repair efficiency goes down with age, then even with a constant level of damage hitting the DNA, the steady state level of unrepaired damage will rise, compromising the genome.

And there is some evidence for reduced DNA repair capacity in older organisms.

What about repairing other molecules, like proteins?

Good question.

Beyond oxidation and glycation, proteins undergo other alterations over time, like deemidation or erasimization.

The main defense against accumulating altered proteins is protein turnover.

Turnover, meaning breaking down old ones and making new ones.

Precisely.

It's like a cellular quality control and recycling program.

But studies show that total body protein turnover decreases with age.

So proteins hang around longer.

Yes.

The average lifetime of many proteins increases.

This makes them more susceptible to accumulating various forms of damage over time, especially those long -lived extracellular matrix proteins like collagen and elastin and connective tissues.

Right.

Contributing to stiffness and loss of function.

What about cell membranes?

Membranes are also vulnerable, particularly to oxidative damage because they're rich in polyunsaturated fatty acids.

Oxidation creates lipid peroxides, which can cause further damage and lead to changes in membrane composition, fewer double bonds, maybe a higher cholesterol to phospholipid ratio.

And what does that do to the membrane?

The main consequence seems to be a reduction in membrane fluidity.

Membranes become stiffer, less flexible.

This can interfere with all sorts of essential functions acting as a barrier, transporting molecules, receiving signals.

Okay, so damage accumulates, repair declines.

What about the number of cells themselves?

Does that change with age?

That's another critical aspect, the dysregulation of cell number.

In most tissues, the number of cells stays pretty constant during adult life, thanks to a balance between cell division and cell death.

But that balance can be disrupted.

Yes.

If cell division becomes excessive or uncontrolled, you can get hyperplasia, like benign prostatic hyperplasia in older men, or worse, neoplasia cancer, which clearly increases in incidence with age.

Too many cells.

What about too few?

An imbalance favoring cell removal or a failure of cell replacement can lead to a reduction in cell number.

We see this in some tissues, like the age -related loss of muscle fibers in skeletal muscle.

Is there a limit to how many times our cells can divide?

That's a fascinating story.

Back in 1961, Leonard Hayflick made a landmark discovery.

He found that normal human fibroblasts grown in culture would only divide a limited number of times, maybe 50 or 60 times, and then stop.

This became known as the Hayflick limit.

So cells have a built -in division counter.

It appears so, at least for many cell types.

This finding spurred intense research into what controls this limit, leading to the discovery of telomeres.

Telomeres?

The caps on the ends of chromosomes.

Exactly.

They're repetitive DNA sequences that protect the ends of chromosomes.

With each normal cell division, a little bit of the telomere isn't replicated, so they gradually shorten.

Like a burning fuse.

Kind of.

When the telomeres become critically short, it signals the cell to stop dividing, entering a state called replicative senescence.

How relevant is this to aging of the whole organism?

It's thought to be relevant mainly for tissues that rely on cell division for maintenance and repair, and where cell numbers tend to decrease with age, like perhaps in the immune system.

It's not thought to be relevant for cells that don't divide in adults, like neurons or cardiac muscle cells.

Are there ways to prevent telomere shortening?

Yes.

Germline cells, sperm and egg precursors, and many cancer cells express an enzyme called telomerase.

Telomerase can add back the repetitive DNA sequences to the telomeres, effectively making these cells immortal in terms of division potential.

Interesting.

So telomere shortening might contribute to the age -related decline in the immune system.

That's one prominent hypothesis, yes.

Telomphocytes, crucial immune cells, have limited replicative capacity, partly due to telomere shortening, which could contribute to reduced immune effectiveness in the elderly.

Okay, so that covers limitations on cell division.

What about how cells are removed?

Cell death.

Right.

There are two main ways cells die.

Necrosis and apoptosis.

Necrosis sounds bad.

It usually is.

Necrosis is typically a response to severe trauma injury, toxins, lack of oxygen.

It's an uncontrolled breakdown.

The cell swells, bursts, lysis, and spills its contents, triggering inflammation in the surrounding tissue.

It's messy.

Okay.

And apoptosis?

Apoptosis is very different.

It's often called programmed cell death.

It's an active gene -driven process that requires energy, ATP.

It's crucial during development for sculpting tissues, and in adults, for removing old, damaged, or infected cells cleanly.

How is it different from necrosis in terms of appearance?

In apoptosis, the cell shrinks, the nucleus condenses, but the cell membrane remains intact initially.

The cell then fragments into small, membrane -bound packages called apoptotic bodies.

Crucially, these are quickly engulfed by neighboring cells or immune cells, so there's no inflammation.

It's a tidy, controlled demolition.

Programmed and clean.

How is apoptosis triggered?

There are several intricate pathways, but they generally fall into two main categories.

Let's not get lost in all the specific protein names, but focus on the concepts.

Okay.

The big picture.

One is the extrinsic pathway.

This is triggered by signals from outside the cell.

Specific molecules bind to death receptors on the cell's surface.

Think of it like getting an external command to self -destruct.

This binding activates a cascade of enzymes inside the cell called casp bases.

Casp bases?

Yes, they are the executioners.

There are initiator casp bases that get activated first, and then they activate a whole army of effector casp bases that chop up key proteins and DNA, dismantling the cell from within.

Okay.

External signal, death receptors, casp bases.

What's the other pathway?

The other main route is the intrinsic or mitochondrial damage pathway.

This is usually triggered by internal stress signals, things like DNA damage, oxidative stress, maybe high calcium levels inside the cell.

Stress from within.

Right.

This stress often leads to changes in the mitochondria.

Specifically, the opening of a large pore in the inner mitochondrial membrane, called the mitochondrial permeability transition pore, MPTP.

MPTP.

What happens when that opens?

It disrupts mitochondrial function, causes swelling, and importantly leads to the release of proteins normally kept inside the mitochondria out into the cytosol.

The most famous one is cytochrome C.

Cytochrome C?

Isn't that part of the electron transport chain?

It is.

But when it gets released into the cytosol, it plays a completely different role.

It binds to other proteins to form a complex called the apoptosome.

Apoptosome.

And this apoptosome structure recruits and activates an initiator casp base, casp base nine, which then kicks off the same downstream effector casp base cascade as the extrinsic pathway leading to cell death.

So both external signals and internal stress can converge on activating these casp base executioners.

Exactly.

And there's another important player involved, especially in response to DNA damage.

The tumor suppressor protein P53.

P53, the guardian of the genome.

That's the one.

If DNA damage is modest, P53 might just halt the cell cycle to allow time for repair.

But if the damage is too severe and irreparable, P53 can actively trigger apoptosis.

It can increase the levels of pro -apoptotic proteins like BACSLUK and decrease anti -apoptotic proteins like BCL2, tipping the balance towards mitochondrial pore opening.

It can also increase the expression of death receptors, boosting the extrinsic pathway.

Wow.

P53 is really central.

So how does dysregulation of apoptosis relate to aging?

It seems to cut both ways.

On one hand, a failure of apoptosis to effectively remove damage to potentially cancer cells could allow these cells to persist and accumulate, increasing the risk of cancer and contributing to tissue dysfunction.

Okay.

Not enough apoptosis.

On the other hand, excessive or inappropriate apoptosis could lead to unnecessary loss of functional cells in various tissues, contributing to age -related decline in organ function, think neurodegenerative diseases or loss of muscle mass.

So maintaining the right balance of apoptosis is crucial, and dysregulation in either direction likely contributes to aging.

That makes sense.

A delicate balance.

Okay, we've covered a lot at the cellular and molecular level.

Let's pull back out now and look at how these changes manifest across the whole body systemic aging.

Right.

Moving from the micro to the macro.

And it's really important to preface this by saying, again, while we can describe typical age -related changes, there is marked individual variation.

Successful aging is possible.

Absolutely.

Some individuals show remarkably little physiological decline, well into old age.

We also see differences between sexes.

Women, for example, tend to experience faster bone loss after menopause.

And you mentioned reserve capacity earlier.

Yes.

That's a key concept.

Many organ systems have significant reserve capacity or redundancy built in.

This means that age -related declines in function might not become apparent under normal resting conditions.

The decline often only shows up when the system is stressed or challenged, or when the loss of function crosses a certain threshold.

Okay.

So what are some of the most noticeable general changes, body composition?

Yes.

Some basic physical changes are quite common.

People generally get shorter with age.

Shorter.

Why?

Peak height is usually reached in the late teens.

After that, there's a slow, progressive decline.

It's mainly due to compression of the cartilaginous discs between the vertebrae and some loss of vertebral bone height itself.

You might lose an inch or two, maybe 2 .5 to 5 % of your peak height, by age 70.

Interesting.

What about weight and fat versus muscle?

That shifts too.

Generally, fat -free mass, everything that isn't fat, so muscle, bone, organs, and lean body mass tend to progressively decrease throughout most of adult life, even in people who remain physically active.

Less muscle and bone mass.

Right.

Conversely, total body fat, the adipose tissue mass, tends to increase, at least up until a very old age, and the distribution changes too.

Fat tends to accumulate more around the abdominal organs, the visceral fat.

The dangerous kind.

Often, yes.

Yeah.

While fat might decrease in the extremities and under the skin on the face, which can contribute to that thinner, more gaunt look sometimes seen in the elderly.

Okay, height loss.

Shift towards more fat, less lean mass.

What about the skin?

That's often the most visible sign.

True.

Skin aging is complex.

We distinguish between intrinsic aging and photo itching.

Intrinsic versus photo aging.

Intrinsic aging refers to the changes that occur even in skin protected from the sun.

The epidermis, the outer layer, tends to thin.

Changes in the dermis, the layer below, include less collagen and elastin, and the collagen becomes stiffer due to cross -linking.

The skin becomes less elastic, less malleable.

And photo itching.

That's the additional damage caused by cumulative exposure to ultraviolet UV radiation from the sun layered on top of intrinsic aging.

This leads to more dramatic changes like coarse wrinkles, leathery texture, and pigment changes.

Age spots.

Makes sense.

What else changes in the skin?

Sweat glands and sebaceous oil glands tend to decrease in number and activity, leading to drier skin.

Hair typically loses pigment, turning gray and may thin.

Fingernails and toenails often grow more slowly.

Okay.

Moving deeper, what about muscles and bones?

You mentioned lean mass decreases.

Yes.

The age -related loss of skeletal muscle mass and function is called sarcopenia.

It's a major contributor to frailty and loss of independence.

Sarcopenia.

What causes it?

It involves both a decrease in the number of muscle fibers and a decrease in the size of the remaining fibers, particularly the fast -twitch type two fibers.

Inactivity certainly plays a role, the use it or lose it principle.

Right.

But there's also an intrinsic aging component.

There seems to be a progressive loss of the motor neurons in the spinal cord that innervate these muscle fibers, especially the ones controlling large, powerful type two motor units.

As these neurons die off, surviving neurons might sprout to re -innervate some of the orphan muscle fibers, leading to fewer but larger motor units.

And that affects muscle control?

Yes.

It can lead to a decrease in fine motor control and coordination.

But here's the really important positive message.

Strength training works.

Even very elderly individuals can significantly increase muscle mass and strength with resistance exercise.

That's fantastic news.

Never too late to build muscle.

What about bone?

Osteoporosis is a big concern.

Huge concern.

Bone is constantly undergoing remodeling old.

Bone is resorbed by cells called osteoclasts, and new bone is formed by osteoblasts.

In youth and early adulthood, formation keeps pace with or exceeds resorption.

Building strong bones.

But starting around middle age, the balance shifts.

Resorption begins to slightly outcase formation, leading to a slow, progressive loss of bone mass in both sexes.

And it accelerates in women.

Dramatically so, right after menopause, due to the loss of estrogen's protective effects.

This significant bone loss leads to osteoporosis, which is technically defined by bone mineral density falling below a certain threshold compared to young adults.

The bones become porous and brittle, vastly increasing the risk of fractures, especially hip, spine, and wrist fractures.

A major geriatric health problem.

What about joints?

Arthritis seems so common.

Yes.

Osteoarthritis, the degenerative kind, is extremely common.

Joint flexibility generally declines with age, partly due to changes in the connective tissues, but also due to changes within the synovial joints themselves.

The articular cartilage that cushions the bone ends tends to thin.

Its mechanical properties change.

It holds less water.

The chondrocyte cells that maintain it become less effective.

Collagen crosslinking increases,

and proteoglycan content decreases.

Lots of changes in the cartilage.

All contributing to cartilage breakdown, pain, stiffness, and the development of osteoarthritis.

Muscles, bones, joints.

Let's move to sensory and motor functions.

How does the nervous system hold up?

Is significant decline inevitable?

That's a common fear.

But actually, in healthy aging meaning, without specific neurodegenerative diseases like Alzheimer's or Parkinson's, the impairment of the nervous system is often much less severe than people think.

That's reassuring.

But there are typical changes, right?

Sensory declines.

Yes.

Most sensory systems do show some age -related decline.

Sensitivity to light touch, vibration sense, and the ability to distinguish two closely spaced points on the skin,

two -point discrimination, tend to decrease.

Proprioception, our sense of body position and movement, can deteriorate, as can the vestibular system in the inner ear, which is crucial for balance.

Thermoregulation, the ability to sense and respond to heat and cold, can also become impaired.

What about the major senses, hearing and vision?

Hearing loss, particularly for high -frequency sounds, presbycusis, is extremely common.

It's often due to the loss of sensory hair cells in the cochlea, the organ of Corti.

But problems with the auditory nerve or blood supply can also contribute.

Importantly, there can also be a central processing deficit, difficulty, filtering out background noise to understand speech, even if the sounds themselves are loud enough.

Making conversations in noisy places difficult.

Very difficult.

For vision, the most common change is the loss of the lens's ability to accommodate or focus for near vision, starting in middle age.

Needing reading glasses?

Exactly.

Other changes can include reduced numbers of cone cells in the retina, affecting color, vision, and acuity, pupils reacting more sluggishly to light changes, and rods adapting more slowly to low light conditions.

And of course, the incidence of age -associated eye diseases like cataracts, glaucoma, and macular degeneration increases significantly.

What about taste and smell?

Does food really taste blander?

There can be some deterioration in the perception of specific taste qualities, but the major change is often a marked reduction in the sense of olfaction, or smell.

Smell declines more than taste.

Generally, yes.

And since much of what we perceive as flavor is actually due to smell, this reduction in olfaction is a major reason why many elderly people report that food tastes bland or pastel.

Fascinating link between smell and flavor perception.

Sensory inputs decline.

What about motor outputs and central processing?

A really major consistent effect of aging on the nervous system is a slowing of reaction time.

The time it takes to perceive a stimulus and initiate a response gets longer.

Just generally slower reflexes.

Yes.

And this slowing becomes more pronounced as the complexity of the required response increases.

This is considered a hallmark of nervous system aging,

a general slowing of central processing speed.

And this affects things like walking and balance.

Absolutely.

Deterioration and posture control imbalance is common, contributing to the high incidence of falls in the elderly, which can have devastating consequences.

Even in healthy elderly people who can walk faster, they often adopt a characteristic walking pattern.

Slower speed, shorter steps, but more frequent steps.

Why that specific pattern?

It's thought to be largely a compensatory strategy.

It helps maintain stability with less flexible joints, provides more time to monitor the environment for hazards with deteriorating sensory systems, and generally improves balance control.

A smart adaptation.

What about higher level cognitive functions, memory, learning?

Is significant decline the norm?

Again, in the absence of dementia,

cognitive decline in healthy aging is generally not marked.

What decline there is often reflects that general slowing of central processing speed we talked about.

So not necessarily losing abilities, just doing them slower.

To a large extent, yes.

The capacity to use knowledge and skills acquired over a lifetime crystallized intelligence is usually well preserved.

It's the ability to solve novel problems quickly.

Fluid reasoning or fluid intelligence that tends to decline more noticeably.

What about memory, forgetting keys, names?

Memory for specific recent events or details like where you put your keys might deteriorate

But conceptual memory, understanding meanings and relationships, usually remains intact.

And older adults are definitely still capable of learning new things, it just might take them a bit longer or require more repetitions.

So cognition holds up reasonably well for many, just slows down a bit.

Okay, let's move to the heart and lungs, the cardiovascular and pulmonary systems.

Sure.

And again, the theme here is that in the absence of specific diseases like coronary artery disease or emphysema, the age -associated changes in these systems at rest are often modest.

Okay, what are the main changes in the cardiovascular system then?

Probably the most consistent and important change is decreased arterial compliance.

The large arteries, like the aorta,

become stiffer, less elastic.

Stiffer arteries, what does that do?

It primarily leads to an increase in systolic blood pressure, the pressure when the heart beats, because the stiff arteries don't expand as easily to accommodate the blood ejected from the heart.

Diastolic pressure, the pressure between beats, might stay the same or even decrease slightly.

The result is a widened pulse pressure, the difference between systolic and diastolic.

And does that affect the heart itself?

Yes.

The increased stiffness of the arteries increases the resistance the left ventricle has to pump against.

This is called increased afterload.

Over time, the heart muscle adapts to this increased workload by thickening its walls.

The individual heart muscle cells, myocytes, get bigger, though their number doesn't really increase.

So the heart works harder.

What about preload, the filling of the heart?

At rest, preload doesn't seem to change much with age.

One common issue, though, is postural hypotension.

Feeling dizzy when you stand up.

Exactly.

A sudden drop in blood pressure upon standing.

This becomes more common, partly because the arterial baroreceptor reflex, which normally detects pressure changes and heart rate and vessel tongue quickly, becomes somewhat blunted or less responsive with age.

Okay.

What about the lungs, the pulmonary system?

We see some decline in the strength and endurance of the respiratory muscles, like the diaphragm and intercostal muscles.

Lung volumes, like vital capacity, the maximum amount of air you can exhale after a deep breath, also tend to decrease.

Lungs become less efficient.

In a way.

A key change relates to the small airways in the lungs.

Due to degeneration of supporting collagen and elastin fibers in the lung tissue, these small airways have an increased tendency to collapse, especially at lower lung volumes.

This is called atelectasis.

Airway collapse.

What's the consequence?

It leads to impaired ventilation of some lung regions.

Air gets trapped and you get a mismatch between where the air is going, ventilation, and where the blood is flowing,

perfusion.

This ventilation -perfusion mismatch is less efficient for gas exchange, and it's a major reason why resting arterial oxygen levels, PO2, tend to decrease slightly with age.

Okay.

How do these systems respond to exercise?

Does that change?

Yes.

The body's maximal capacity for aerobic exercise, measured as maximal oxygen uptake, VO2 max, progressively declines with age, even in trained athletes, although training helps maintain a higher level.

How does the cardiovascular system adapt differently during exercise in older adults?

When an older person exercises, their heart rate typically doesn't increase as much as a younger person's would for the same relative workload.

To compensate and maintain cardiac output, they rely more on increasing their stroke volume, the amount of blood pumped per beat, often by utilizing the Frank Starling mechanism, basically, stretching the heart muscle more during filling to get a stronger contraction.

Different strategy to achieve the same goal.

Can older people still benefit from exercise training?

Absolutely.

This is crucial.

While the magnitude of the training response might decrease somewhat with age, both skeletal muscle and the cardiovascular system remain remarkably responsive to physical conditioning, even into the tenth decade of life.

Exercise offers profound benefits at any age.

That's incredibly encouraging.

Okay.

Two more systems.

Renal and GI.

Kidneys first.

Renal function, specifically the glomerular filtration rate, GFR,

which measures how well the kidneys filter waste from the blood, has an interesting story.

Cross -sectional studies consistently show a steady linear decline in average GFRs starting around age 30.

So kidney function just goes down for everyone.

That's what it looked like.

But then longitudinal studies following the same people over time revealed a more nuanced picture.

It turns out that this decline is not inevitable for every individual.

Really?

Yeah.

Roughly a third of people showed the expected decline, maybe another third showed an even steeper decline, but a remarkable one -third of individuals showed no significant decline in GFR, even into old age.

Wow.

So kidney aging varies a lot.

Any other kidney changes?

Yes.

Transport functions in the renal tubules tend to decrease, affecting the ability to concentrate or dilute urine as effectively.

Bladder capacity and compliance, stretchiness, often decrease, while uninhibited contractions might increase, contributing to urinary frequency or incontinence issues.

Okay.

And the gastrointestinal system?

Does digestion slow down?

Surprisingly, for the most part, gastrointestinal function is largely preserved in healthy aging.

Many common beliefs, like decreased stomach acid, aren't actually due to aging itself.

Oh.

What causes the acid decrease then?

It's usually linked to chronic infection with the bacterium Helicobacter pylori, which becomes more common with age, leading to atrophic gastritis.

In healthy elderly, without age pylori, acid secretion is generally maintained.

Good to know.

Any GI changes that are age -related?

There can be minor decreases in chewing efficiency, swallowing coordination, or fecal continence, often related to muscle loss or neurological changes.

Some exocrine grand secretions might decrease slightly.

The most significant changes are probably in the liver.

What happens to the liver?

Liver mass and hepatic blood flow tend to decrease significantly with age.

This reduces the liver's capacity to metabolize certain drugs, increasing the risk of adverse drug reactions.

Hepatic regeneration after injury also slows down.

Important for medication management in the elderly.

Okay, last system.

The endocrine system.

Hormones.

Right.

Overall, the endocrine system shows relatively modest functional declines compared to some other systems.

One general change is that total daily energy expenditure decreases with age.

People burn fewer calories.

Yes, but that's primarily because physical activity levels tend to decrease, and there's that loss of metabolically active lean body mass we discussed.

Interestingly,

the resting metabolic rate per kilogram of fat -free mass doesn't really decrease significantly.

The lower overall metabolic rate just reflects having less fat -free mass.

Got it.

What about specific hormone changes?

Insulin.

Diabetes risk increases with age.

Yes, glucose cholera tends to become impaired with age.

This is mostly due to increased insulin resistance, meaning the body's cells don't respond as well to insulin.

While there might be a small intrinsic aging effect, this increased resistance is largely driven by the increase in adiposity, especially visceral fat.

Serum LDL cholesterol also tends to increase.

What about growth hormone?

There's a notable decline here.

Peak growth hormone, GH concentrations, especially the pulses that occur during sleep, diminish significantly with age.

This leads to substantially lower levels of its downstream mediator, insulin -like growth factor 1, IGF -1, produced mainly by the liver.

Lower GH and IGF -1, any other key adrenal or thyroid changes?

From the adrenal cortex, cortisol secretion is largely preserved.

Aldosterone levels might decrease slightly, but the most dramatic change is a marked decrease in the production of DHEA, dehydrapin drosterone, and its sulfate DHEAs.

DHEA drops off significantly, and the thyroid.

Thyroid function is generally well -maintained until very old age, maybe the ninth decade or beyond.

In centenarians, TSH might decline, and levels of the active thyroid hormone, free T3, may fall.

Interestingly, parathyroid hormone, PTH levels, tend to increase with age.

Okay.

And finally, the gonads,

sex hormones.

Here, there's a very clear difference between the sexes.

In women, menopause marks a relatively abrupt cessation of ovarian function and estrogen production, typically around age 50.

It's a clear end point.

Yes.

In men, the decline is much more gradual.

There's a progressive decrease in testicular function and testosterone production, often starting in middle age and continuing into old age.

This is sometimes referred to as andropause, though it's less abrupt and universal than menopause.

Okay.

That covers the systemic changes.

Now, for our final section, the big question, can we actually slow down aging?

The quest for longevity.

Humans have dreamed of extending life forever, it seems.

And we have achieved a lot in the last century, as we said at the start.

We have.

But it's crucial to reiterate that the dramatic increase in average life expectancy during the 20th century was primarily achieved by preventing premature deaths.

Reducing deaths from infections, accidents, better sanitation, safer environments.

Exactly.

We got much better at helping people reach old age, but we haven't necessarily slowed down the intrinsic rate of the aging process itself, at least not to the same extent.

Evidence for this is that the maximal lifespan of humans, how long the oldest old individuals live, hasn't changed nearly as dramatically as the average lifespan.

It's remained relatively stable for centuries.

So pushing the average up, but not necessarily the ceiling, is there anything known that does seem to slow the fundamental aging process?

There is one intervention that stands out, experimentally at least, with remarkable consistency across many species.

Caloric restriction, or CR.

Eating less.

Essentially, yes.

Eating significantly fewer calories than would be consumed voluntarily, but without causing malnutrition -maintaining essential nutrients.

This was first clearly shown by Clive McKay back in 1935 with the rats.

What did he find?

He found that rats fed a nutrient -rich diet, but with significantly restricted calories, lived much longer.

Both their average and their maximum lifespan increased dramatically, compared to rats allowed to eat freely.

If you visualize the survival curves, the CR rat's curve would extend far, far to the right.

Wow.

Does it work in other animals?

It's remarkably widespread.

CR has been shown to extend lifespan in mice, hamsters, dogs, fish, spiders, worms, flies, yeast,

numerous species.

Long -term studies in rhesus monkeys are also showing significant health benefits and trends towards increased longevity.

So why do scientists think CR actually slows aging, rather than just preventing specific diseases?

Because CR animals don't just live longer.

They seem to maintain youthful physiological function for longer.

They show delayed onset and reduced incidence of a whole spectrum of age -associated diseases.

Cancers, kidney disease, autoimmune problems.

They generally appear biologically younger than their freely fed counterparts at the same chronological age.

Okay, so it seems to affect the underlying process.

How might it work?

What are the mechanisms?

That's the million -dollar question.

And it's likely multifactorial.

Several leading hypotheses are being actively researched.

What's number one?

One major idea is that CR leads to decreased oxidative stress.

Restricted animals often show lower levels of accumulated oxidative damage to proteins, lipids, and DNA as they age.

Lower damage.

Makes sense.

What else?

Second, CR typically leads to lower average blood glucose levels.

This could reduce glycation and the formation of those damaging AGEs we talked about earlier.

Less sugar damage.

Okay.

Third, and this is a really hot area, CR causes significant and sustained reductions in plasma insulin and IGF -1 levels.

And numerous genetic studies, which we'll touch on, strongly suggest that decreasing activity in this insulin IGF -1 signaling pathway is a conserved mechanism for extending lifespan across species.

Ah, connecting back to those growth -related hormones.

Interesting.

Any other ideas?

A fourth concept is hormesis.

Hormesis.

Hormesis is the idea that mild repeated stress can actually induce protective responses in cells and organisms, making them more resistant to subsequent, more severe stress.

CR can be viewed as a mild, chronic metabolic stress.

And indeed, CR animals often show enhanced ability to cope with acute challenges like heat shock or toxins.

They seem generally more robust.

So multiple potential pathways contributing to CR's effects.

Fascinating.

You mentioned genetics and the insulin IGF -1 pathway.

Can specific genes influence longevity?

Oh, absolutely.

Genetics plays a huge role.

It's obvious from the vast differences in lifespan between species, but also within species, longevity clearly has a heritable component.

But it's complex, right?

Many genes involved.

Likely very complex, involving potentially hundreds or thousands of genes interacting.

However, researchers have made some truly stunning discoveries showing that mutations in just a single gene can sometimes have profound effects on lifespan.

Single genes, like what?

The classic example comes from the nematode worm, C.

elegans.

Mutations in a gene called H1, which is part of that insulin IGF -1 signaling pathway, were found to dramatically increase the worm's lifespan.

Similar findings came from mutations of the DAF2 gene, the worm's insulin IGF -1 receptor.

So dialing down that pathway in worms makes them live longer.

What about in mammals, like mice?

Yes, similar principles seem to apply.

Several mouse models are really striking.

For instance, Ames wharf mice have a genetic mutation that prevents their pituitary gland from producing growth hormone, GH, TSH, and prolactin.

They end up with low levels of thyroid hormone, very low IGF -1, and low insulin.

And they live significantly longer than normal mice.

Wow, dwarf mice live longer.

Any others?

Mice where the receptor for growth hormone has been knocked out, GHR knockout mice, also show growth retardation, high GH levels, but very low IGF -1, and also live considerably longer.

Again, messing with GHIGF -1 signaling.

Exactly.

Even reducing the expression of the insulin receptor itself,

specifically in mouse adipose tissue, led to significant life extension.

And then there's the Clotho gene.

Yes, mice engineered to overexpress the Clotho gene produce more of the Clotho protein.

This protein acts, in part, to suppress insulin and IGF -1 signaling.

And what happens?

These mice live longer.

It all seems to point towards that insulin IGF -1 pathway being a key regulator.

It really does seem to be a central, evolutionarily conserved pathway influencing aging and longevity.

There's also work on other pathways, like involving sirtuins proteins related to the Sirtu gene in yeast, which also affects lifespan.

But the insulin IGF -1 link is particularly strong.

This is all fascinating research, but it brings us to the more controversial side of things, anti -aging medicine.

It's become quite popular, often focusing on lifestyle interventions like diet and exercise to prevent age -associated diseases, which is generally sound advice.

Right.

Promoting healthy aging is a valid goal.

But then you hear claims from some practitioners or companies selling supplements about specific magic bullets, antioxidants, amino acids, maybe drugs like Deprentol or hormones like melatonin, DHEA, even growth hormone or testosterone, claiming they can actually slow or reverse the aging process itself.

Yes, those claims are widespread.

And this is where we need to be extremely cautious and evidence -based.

So what does the credible scientific evidence say about these alleged anti -aging agents?

Let me be absolutely clear.

No credible scientific evidence indicates that any of these commonly marketed agents will reverse or even slow the fundamental process of human aging.

None of them, despite the claims.

Despite the claims.

There's simply no rigorous long -term clinical trial data in humans to support such assertions for any of these substances.

And is there a risk of harm?

Absolutely.

Beyond the lack of efficacy, there's a very real possibility of long -term adverse effects that we just don't know about yet.

History gives us cautionary tales.

Like what?

Think about combined estrogen and progestin hormone replacement therapy for postmenopausal women.

It was widely prescribed for years, hailed for relieving symptoms, and thought to protect the heart based on observational studies.

Right.

It was standard practice.

It was.

Until large, well -designed, randomized controlled trials, like the Women's Health Initiative, were finally conducted.

And they revealed that, contrary to expectations, this therapy actually increased the risk of cardiovascular disease, stroke, and breast cancer in certain populations.

Wow.

A complete reversal based on better evidence.

A stark reminder of why rigorous trials are essential before widespread adoption.

And it makes one concerned about, for example, the current off -label use of recombinant growth hormone for anti -aging.

Why the concern there?

Because, as we just discussed, the animal studies with genetic manipulations consistently suggest that decreasing GH and IGF -1 signaling tends to extend lifespan.

While increasing, it might even promote aging or age -related diseases.

So giving GH to older adults, even if it temporarily increases muscle mass, could potentially have long -term detrimental effects that we don't yet understand.

A very serious potential downside based on the basic science.

Exactly.

The bottom line is, we desperately need well -designed long -term studies in humans before any agent can be legitimately claimed to slow aging.

Right now, the evidence just isn't there for these purported magic bullets.

That's a crucial takeaway.

So as we wrap up this really comprehensive deep dive, we've journeyed all the way from the big picture of population shifts and the evolutionary why of aging.

Right down into the cellular nitty -gritty.

Exploring oxidative stress, glycation, DNA damage, repair failures, telomeres, apoptosis, all those intricate mechanisms.

Then we saw how these manifest systemically, affecting everything from our skin and bones to our heart, lungs, brain, and hormones, remembering that huge individual variability.

And finally, we look at the science behind trying to slow aging, the solid evidence for caloric restriction in animals, the fascinating genetic links, and the crucial lack of evidence for most popular anti -aging interventions.

It's been a lot of ground to cover.

It really has.

This was a dense but incredibly important exploration of the physiology of aging.

And by breaking it down, hopefully, you've gained a solid foundational understanding of these complex concepts.

Remember, you are part of the deep dive family, and you are absolutely capable of mastering this material.

Keep digging.

Absolutely.

And to leave you with something to think about, if our understanding of aging's genetic and molecular underpinnings does continue to advance, and we develop interventions that could genuinely extend human lifespan significantly beyond what we currently see, what ethical considerations might arise them?

What would that mean for individuals and for society as a whole?

Something to ponder until our next deep dive.